Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report) shot up 2% during trading on Thursday . The company traded as high as $0.29 and last traded at $0.29. 192,729 shares changed hands during trading, a decline of 93% from the average session volume of 2,862,480 shares. The stock had previously closed at $0.28.
Azitra Trading Up 2.0%
The stock has a 50-day moving average price of $0.29 and a 200 day moving average price of $0.38.
Institutional Investors Weigh In On Azitra
A hedge fund recently raised its stake in Azitra stock. Virtu Financial LLC boosted its position in Azitra, Inc. (NYSEAMERICAN:AZTR – Free Report) by 196.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 63,180 shares of the company’s stock after buying an additional 41,866 shares during the quarter. Virtu Financial LLC owned approximately 0.83% of Azitra worth $27,000 as of its most recent filing with the SEC. 11.16% of the stock is owned by hedge funds and other institutional investors.
About Azitra
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Further Reading
- Five stocks we like better than Azitra
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What Are Earnings Reports?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
